1. Home
  2. ARCT vs NETD Comparison

ARCT vs NETD Comparison

Compare ARCT & NETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • NETD
  • Stock Information
  • Founded
  • ARCT 2013
  • NETD 2023
  • Country
  • ARCT United States
  • NETD United States
  • Employees
  • ARCT N/A
  • NETD N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • NETD
  • Sector
  • ARCT Health Care
  • NETD
  • Exchange
  • ARCT Nasdaq
  • NETD Nasdaq
  • Market Cap
  • ARCT 373.7M
  • NETD 422.4M
  • IPO Year
  • ARCT N/A
  • NETD 2023
  • Fundamental
  • Price
  • ARCT $14.94
  • NETD $11.17
  • Analyst Decision
  • ARCT Strong Buy
  • NETD
  • Analyst Count
  • ARCT 8
  • NETD 0
  • Target Price
  • ARCT $52.83
  • NETD N/A
  • AVG Volume (30 Days)
  • ARCT 443.2K
  • NETD 243.1K
  • Earning Date
  • ARCT 08-04-2025
  • NETD 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • NETD N/A
  • EPS Growth
  • ARCT N/A
  • NETD N/A
  • EPS
  • ARCT N/A
  • NETD 0.34
  • Revenue
  • ARCT $143,680,000.00
  • NETD N/A
  • Revenue This Year
  • ARCT N/A
  • NETD N/A
  • Revenue Next Year
  • ARCT $34.08
  • NETD N/A
  • P/E Ratio
  • ARCT N/A
  • NETD $32.80
  • Revenue Growth
  • ARCT 15.38
  • NETD N/A
  • 52 Week Low
  • ARCT $8.04
  • NETD $10.58
  • 52 Week High
  • ARCT $25.88
  • NETD $11.47
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 60.54
  • NETD 54.61
  • Support Level
  • ARCT $12.75
  • NETD $10.96
  • Resistance Level
  • ARCT $15.83
  • NETD $11.24
  • Average True Range (ATR)
  • ARCT 0.86
  • NETD 0.12
  • MACD
  • ARCT 0.12
  • NETD 0.00
  • Stochastic Oscillator
  • ARCT 71.10
  • NETD 41.18

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About NETD Nabors Energy Transition Corp. II

Nabors Energy Transition Corp II is a blank check company.

Share on Social Networks: